Research and Markets: The Executive Guide to Molecular Imaging: Molecular Imaging Estimated to Be Worth US$45 Billion By 2010
Posted on: Monday, 17 May 2004, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com) has announced the addition of The Executive Guide to Molecular Imaging to their offering.
A plain-English review of the research, technology and developers that are driving a market estimated to be worth US$45 billion by 2010.
Molecular imaging (MI) is the measurement and imaging of biological processes in living organisms at the molecular and cellular level.
It is a newly-evolving technology which combines molecular agents with advanced imaging tools to capture pictures of specific molecular pathways in the body, particularly disease targets. It could transform healthcare and the health industry.
The clinical benefits of this technology are clear. If potentially lethal conditions such as cancer or cardiovascular disease can be detected before they have taken hold, patient outcomes would improve vastly and healthcare costs would decline as the need for surgery or later-stage treatments decrease.
The commercial opportunities are no less impressive. Pharmaceutical developers can use information gained to identify and develop drugs that target specific molecular structures, while imaging and diagnostic companies have much to gain from the need for advanced imaging equipment and contrast media.
This highly informative 100-page report is based on extensive primary academic and commercial research. The report distils the current thinking on MI and identifies the companies and organisations that are developing products/technology. Extensive contents include:
Medical Device Companies Including:
-ABX Advanced Biochemical Compounds
-Advanced Research Technologies
-Bioscan
-CTI Molecular Imaging
-Cytogen
-Gamma Medica
-GE Medical Systems
-Immunomedics
-Kereos
-Lightools Research
-Mediscience Technology
-Mallinckrodt (Tyco)
-Macrocyclics
-Philips Medical Systems
-Schering-Siemens Medical Solutions
Academic & Research Institutes Worldwide
The work of over 25 institutions including:
-Harvard MedicalSchool
-John Hopkins University
-Mayo Clinic
-National Cancer Institute
-NIH
-NIBIB
-Stanford University
-University of California
-VA Medical Centre
-Washington University
-University Hospital Innsbruck
-Universities of Hamburg and Marburg
-Centre of Molecular Imaging (Norway)
-Uppsala University
-Queens University, Belfast
-University of Manchester
For more information visit http://www.researchandmarkets.com/reports/c2049
Related Articles
- Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
- Outpatient Imaging Affiliates Partners With Wake Forest University Baptist Medical Center to Develop Outpatient Imaging Center in Winston-Salem
- Wake Forest University Baptist Medical Center Ramps Up Cancer Treatment Capabilities With Stereotactic Systems From Elekta
- Research and Markets: This Report on Covidien Ltd. Tyco Healthcare Medical Equipment Company is Now Available
- Research and Markets: Fresenius Medical Care Company Intelligence Report Reveals Products, International Activities and R&D, As Well As a Full, In-Depth Five Year Financial Analysis
- Research and Markets: Gain an Insight into the Latest Mergers and Acquisitions Undertaken By Therakos the Medical Devices Company
- IBM Announces Winners of Shared University Research Awards
- NovaShunt AG, a Medical Device Company Focused on Implantable Fluid Management Systems, Appoints Fiona Sander, MSME, As Director of Research & Clinical Affairs
- Medical Broadcasting Company Hires Navarrow Wright to Lead Technology Group
- Mississippi State University Research May Lead To New Treatments for Bacterial Infections
 |
 |
User Comments (0)
RSS Feeds